Could These 2 High-Yield Dividend Stocks Double?

Could These 2 High-Yield Dividend Stocks Double?

Explore stocks on Coinbase

Dividend investing is great when it's done right, but finding a stock that lets you sit back and collect a quarterly payout isn't always easy. You have to choose the right stocks, monitor them, and make sure they don't turn into yield traps -- dividend payers that offer a high yield only because the business is declining, putting them at risk of a dividend cut. It's also a challenge to find dividend stocks that can grow their stock price over time as well as their dividend.

Some of these high-yield dividend stocks, however, do have the potential to safely deliver solid gains on both fronts. Let's look at two such stocks that could double in price under the right circumstances.

A stock chart moving higher.
Image source: Getty Images.

1. Philip Morris International

Philip Morris International (NYSE: PM) might seem like a surprising choice. After all, it's no secret that cigarette consumption has been declining for years, but Philip Morris is more than a conventional tobacco company.

The No. 1 brand in its portfolio for growth had long been Marlboro, but that is no longer the case. It's now Iqos, its heat-not-burn product that has been growing rapidly around the world, paving the way for the company's transition away from smoking. Iqos now accounts for more than 50% of revenue in 25 of the company's markets, and smoke-free products generated nearly 40% of revenue and gross profit of more than 40% year over year in the fourth quarter.

Of Philip Morris' $9 billion in revenue, $3.6 billion came from smoke-free products, and revenue from that category jumped 13.6% year over year in the quarter, driving overall revenue up 8.3% to $9 billion.

Management has also managed the decline of its cigarette business well; cigarettes sold fell by just 1.4% to 613 billion in 2023, while heated tobacco units grew by 14.7% to 125 billion.

In addition to Iqos, the company has a number of other fast-growing smoke-free products, including nicotine pouches like Zyn, and Snus, a Swedish oral tobacco product, both of which it gained in its acquisition of Swedish Match in 2022. Sales of nicotine pouches more than tripled year over year in the U.S. in the fourth quarter to 116.3 million units, and sales of Scandinavia-focused Snus rose 41% year over year to 57.1 million, a clear sign of success with those products.

Profits continued to grow despite the decline in cigarette volumes, with adjusted operating income up 3.3%, or 3.7% on an organic basis to $13.3 billion. And profit growth could accelerate as its rising smoke-free business makes up more of overall revenue.